Jay Heller, VP, Head of Capital Markets, Nasdaq In 2024, we proudly welcomed leading IPOs including Lineage, Kaspi.kz, Waystar, BrightSpring Health Services, and Onestream. You're in great company ...

Kestra will join what’s been a strong start to the year for U.S. healthcare IPOs with seven companies raising $1.1 billion ...

The Nasdaq IPO Pulse Index continued ... So, we’re seeing more and bigger IPOs. The IPOs were pretty evenly spread across sectors. Health Care led the way, with about a third of IPOs (chart ...

TOKYO and NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Spirit Advisors LLC proudly announces the successful completion of the initial public offering (IPO) of PicoCELA Inc. (Nasdaq: PCLA), a pioneer in ...

And based on our IPO Pulses, IPO activity looks likely to stay in an uptrend into mid-year – especially in the U.S. Of course, a lot can change over the course of a year, so we’ll be updating our ...

Nasdaq (Nasdaq: NDAQ) announced today that in 2024, it welcomed 171 initial public offerings (IPOs), raising a total of $22.7 billion. A total of 123 operating companies and 48 SPACs listed on ...

Ascentage Pharma Group International (HK:6855) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter ...

The California-based company is set to begin trading on the Nasdaq, with 7.5 million shares priced between $14 and $16 apiece under the ticker BBNX—an IPO range that would give Beta Bionics ...

Maze Therapeutics ( NASDAQ: MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...